Loading...
NPI 1588805451 · Ruskin, FL · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
American Clinical Solutions LLC is a clinical medical laboratory provider located in Ruskin, Florida. This profile covers 4 Medicare and 48 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | American Clinical Solutions LLC |
| Address | 721 Cortaro Dr |
| City | Ruskin |
| State | FL |
| ZIP | 33573 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | March 23, 2009 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $3.8M |
| Medicare | $471.5K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
4 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 1,310 | $240 | $317K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 720 | $150 | $109.5K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 430 | $60 | $26.2K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 100 | $200 | $18.5K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 4 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
48 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 9,910 | $30 | $287.2K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 5,540 | $40 | $194K |
| 80325 | The lab analyst measures the amount of or detects the presence of three or four amphetamines, a central nervous system stimulant in the patient specimen. | 9,760 | $20 | $175.8K |
| 80345 | The lab analyst measures the level of or detects the presence of barbiturates in a patient sample, primarily a serum or urine specimen. Clinicians commonly prescribe barbiturates, especially short… | 11,150 | $10 | $144.9K |
| 83992 | The lab analyst measures the level of this drug, phencyclidine, typically in a urine or blood sample. This very potent street drug is a common drug of abuse. | 11,000 | $10 | $121K |
| 80365 | The lab analyst measures the amount of or detects the presence of oxycodone, a synthetic opioid pain medication, in a patient specimen. | 11,490 | $10 | $114.9K |
| 80361 | The lab analyst measures the amount of or detects the presence of one or more opiates, narcotic analgesics that depress the central nervous system, in the specimen. | 11,460 | $10 | $114.6K |
| 80356 | The lab analyst measures the amount of or detects the presence of heroin metabolite in the patient specimen. | 11,400 | $10 | $114K |
| 80354 | The lab analyst measures the amount of or detects the presence of fentanyl in the patient specimen. | 11,240 | $10 | $112.4K |
| 80358 | The lab analyst measures the amount of or detects the presence of methadone in the patient specimen. | 11,230 | $10 | $112.3K |
Showing 1–10 of 48
How this provider's Medicaid billing volume and revenue compare to other Florida providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Florida median
48 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 7 | 40 | 320 | $100 | $620K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 25 | 50 | 360 | $40 | $96.2K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 76 | 450 | 1,380 | $20 | $75.1K |
| 80325 | The lab analyst measures the amount of or detects the presence of three or four amphetamines, a central nervous system stimulant in the patient specimen. | 2 | 10 | 4,400 | $10 | $64.3K |
| 80339 | The lab analyst measures the amount of or detects the presence of one to three antiepileptics in a patient specimen. The antiepileptics the provider is testing for are not specified in other CPT®… | 3 | 10 | 4,390 | $10 | $62K |
| 80324 | The lab analyst measures the amount of or detects the presence of one or two amphetamines, a central nervous system stimulant in a patient specimen. | 14 | 30 | 420 | $20 | $45K |
| 80338 | The lab analyst measures the amount of or detects the presence of antidepressants, which are psychiatric medications, in a patient specimen. The antidepressants the provider is testing for are not… | 6 | 10 | 4,980 | $1 | $34K |
| 80334 | The lab analyst measures the amount of or detects the presence of six or more serotonergic antidepressants, which are psychiatric medications, in a patient specimen. | 3 | 10 | 4,740 | $10 | $34K |
| 80323 | The lab analyst identifies and evaluates the level of alkaloid drugs in a patient specimen that are not specified elsewhere in CPT® by a different code from the class of alkaloids. | 5 | 20 | 850 | $10 | $30.2K |
| 80346 | The lab analyst measures the amount of or detects the presence of one to twelve benzodiazepines, which are tranquilizers, in a patient specimen. | 5 | 30 | 1,240 | $10 | $28.2K |
Showing 1–10 of 48
Other providers in the same ZIP code as American Clinical Solutions LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Dva Healthcare Renal Care Inc | FL | End-Stage Renal Disease (ESRD) Treatment Clinic/Center | $0 | $9M |
| Sun City Center Ambulatory Surgery Center, LLC | FL | Ambulatory Surgical Clinic/Center | $2.4M | $273.5K |
| Vedashree Panthulu | FL | Rheumatology Physician | $2.4M | $35.6K |
| Byung-joon Ahn | FL | Ophthalmology Physician | $2.1M | $0 |
| Renjitha Ignatius | FL | Medical Oncology Physician | $2.1M | $0 |
| Shahid Malik | FL | Cardiovascular Disease Physician | $788.1K | $540 |
| John Steel | FL | Radiation Oncology Physician | $781.6K | $0 |
| Ronald Patrick | FL | Dermatology Physician | $777.8K | $0 |
| Kortney Hightower | FL | Dermatology Physician | $713.2K | $0 |
| Randy Kahn | FL | Radiation Oncology Physician | $453.4K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.